STRUCTURE AND PHARMACOLOGY OF CHOLINERGIC PROTEINS
STRUCTURE AND PHARMACOLOGY OF CHOLINERGIC PROTEINS
批准号:
3478401
负责人:
STEWART N ABRAMSON
金额:
$10.54万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-30 至 1997-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Acetylcholinesterase is the enzyme responsible for the hydrolysis of
acetylcholine, while nicotinic acetylcholine receptors contain
cation-selective channels that open in response to binding acetylcholine.
These two proteins play central roles in cholinergic neurotransmission,
and they are therefore essential for normal neuronal function. Drugs
that affect their activity are widely used as insecticides, as adjuvants
in surgical anesthesia, and as therapeutic agents for the treatment of
glaucoma, paralytic ileus, atony of the urinary bladder, and myasthenia
gravis. All of the clinically useful drugs that affect the activity of
these proteins do so by interacting with their acetylcholine-recognition
sites. Therefore, structural and pharmacological characterization of
these sites is essential for understanding the function of these proteins
and for developing new and more useful drugs.
The research proposed herein is directed towards the structural and
functional characterization of the acetylcholine-recognition sites of
acetylcholinesterase and the nicotinic acetylcholine receptor. In the
first stage of the project an emphasis will be placed on using small,
covalent, active-site directed affinity reagents to directly identify
amino acids within the acetylcholine-binding sites. Examples include
synthetic active-site directed crosslinking reagents, and the naturally
occurring toxins onchidal and lophotoxin. (Onchidal and lophotoxin are
active-site directed covalent inhibitors of acetylcholinesterase and
nicotinic acetylcholine receptors, respectively). In the second stage of
the project the amino acids identified with the active-site directed
affinity reagents will be altered by site-directed mutagenesis and their
function will be assessed by heterologous expression. Integration of
experimental pharmacology, medicinal chemistry, protein chemistry, and
molecular biology will increase our understanding of the molecular
mechanisms by which these important proteins recognize and bind
acetylcholine. As a result, such studies will ultimately aid in the
design of new and more useful drugs and insecticides.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STRUCTURE AND PHARMACOLOGY OF CHOLINERGIC PROTEINS
-
批准号:3478402
-
项目类别:
-
资助金额:$4.25万
-
财政年份:1992
-
负责人:STEWART N ABRAMSON
-
依托单位:
STRUCTURE AND PHARMACOLOGY OF CHOLINERGIC PROTEINS
-
批准号:2268029
-
项目类别:
-
资助金额:$9.69万
-
财政年份:1992
-
负责人:STEWART N ABRAMSON
-
依托单位:
STRUCTURE AND PHARMACOLOGY OF CHOLINERGIC PROTEINS
-
批准号:2268030
-
项目类别:
-
资助金额:$10.11万
-
财政年份:1992
-
负责人:STEWART N ABRAMSON
-
依托单位:
STRUCTURE AND PHARMACOLOGY OF CHOLINERGIC PROTEINS
-
批准号:2268031
-
项目类别:
-
资助金额:$10.52万
-
财政年份:1992
-
负责人:STEWART N ABRAMSON
-
依托单位:
STRUCTURE AND PHARMACOLOGY OF CHOLINERGIC PROTEINS
-
批准号:3510007
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1991
-
负责人:STEWART N ABRAMSON
-
依托单位:
STRUCTURAL CHARACTERIZATION OF THE MUSCARINIC RECEPTOR
-
批准号:3040874
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1987
-
负责人:STEWART N ABRAMSON
-
依托单位:
STRUCTURAL CHARACTERIZATION OF THE MUSCARINIC RECEPTOR
-
批准号:3040873
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1986
-
负责人:STEWART N ABRAMSON
-
依托单位:
STRUCTURAL CHARACTERIZATION OF THE MUSCARINIC RECEPTOR
-
批准号:3040872
-
项目类别:
-
资助金额:$1.9万
-
财政年份:1985
-
负责人:STEWART N ABRAMSON
-
依托单位:
海外基金